Navigation Links
Eurand's Zentase Effective in Treating Exocrine Pancreatic,Insufficiency, Studies Show

n contained in this release, constitutes forward-looking statements. Such forward-looking statements include those which express plan, anticipation, intent, contingency, goals, targets or future development and/or otherwise are not statements of historical fact including, but not limited to our plans for our NDA filing, enrollment and future plans for our clinical trials, progress of and reports of results from clinical studies, clinical development plans and product development activities. The words "potentially", "could", "calls for" and similar expressions also identify forward-looking statements. These statements are based upon management's current expectations and are subject to risks and uncertainties, known and unknown, which could cause actual results and developments to differ materially from those expressed or implied in such statements. Factors that could affect actual results include risks associated with the possibility that the FDA refuses to approve our NDA; the outcome of any discussions with the FDA; and unexpected delays in preparation of materials for submission to the FDA as a part of our NDA filing. Forward- looking statements contained in this press release are made as of this date, and we undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Actual events could differ materially from those anticipated in the forward- looking statements.

    (1) Littlewood, James M., and Susan P. Wolfe. "Control of Malabsorption

        in Cystic Fibrosis." Paediatric Drugs (2000; 2 : 205-22)

    (2) Guidance for Industry Exocrine Pancreatic Insufficiency Drug Products

        - Submitting NDAs. U.S. Department of Health and Human Services, Food

        and Drug Administration (FDA), Center for Drug Evaluation and Research

        (CDER), April 2006

    (3) United States Pharmacopeia (USP) standards for pancreatic enzyme

        products (will get full refer
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Eurand to Present Zentase Phase III Data
2. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
3. Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis
4. Gabapentin Shown Effective for Fibromyalgia Pain
5. ApoCells Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
6. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
7. XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine or Vinorelbine in Treating Non-Small Cell Lung Cancer
8. Soliris Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
9. Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and Effective in Colorectal Cancer with Liver Metastases
10. Biotheras Imprime PGG Enhanced Effectiveness of Avastin in Cancer Study
11. Targanta Study Shows Oritavancin Treatment Effective in a Mouse Model of Anthrax
Post Your Comments:
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/g5r2nj/surgical_incision ) has announced ... Strategic Business Report" report to their offering. ... Canada , Japan , ... Latin America , and Rest of World. ... Closures in US$ Million by the following Product Segments: Stapler ...
(Date:6/2/2015)... BOSTON , June 2, 2015 ... an additional $75 million from its recently announced synthetic ... raised to $300 million. Investors have purchased Convertible Limited ... quarterly payments equal to 2.0% of any future global ... or are fully paid. Investors also have the option, ...
(Date:6/2/2015)... Stoltenberg Consulting , a leading ... the celebration of its 20-year anniversary and over ... its inception in 1995. "As ... healthcare technology industry continues, we strive to combine ... facilitating clients, organizational goals, understanding that today,s healthcare ...
Breaking Medicine Technology:Surgical Incision Closures - Global Strategic Business Report 2015 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 3Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 2Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 3
... Posit Science Corporation,announced today that enrollment has completed ... program designed to enhance memory. The,IMPACT ("Improvement in ... enrolled more than five hundred adults aged 65+,seeking ... scientific,research. Principal Investigators for the IMPACT trial ...
... PALO ALTO, Calif., Oct. 18 Avicena ... biotechnology company that,develops central nervous system therapeutics ... to the Company,s Amyotrophic,Lateral Sclerosis (ALS) drug ... International Symposium on ALS/MND which will be ...
Cached Medicine Technology:Study Demonstrates Mindful Approach to Aging 2Study Demonstrates Mindful Approach to Aging 3Survival Data for Avicena's Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND 2Survival Data for Avicena's Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND 3
(Date:6/2/2015)... FL (PRWEB) June 02, 2015 MedPro ... staffing services to healthcare facilities, today announced the worldwide ... and effective mobile tool to help candidates find best ... Glassdoor survey released in 2014, 9 in 10 job ... during their job search. , The MedPro Top Jobs ...
(Date:6/2/2015)... RI (PRWEB) June 02, 2015 ... equipment distributor, has announced the acquisition of ... equipment distributor, effective May 29th, 2015. , With CME’s ... 2015, this latest acquisition joins three premier organizations which ... to hospitals and healthcare facilities. By combining forces, they ...
(Date:6/2/2015)... 02, 2015 MAP Health Management, LLC, ... cycle management for addiction treatment facilities, announced today that ... of Marketing. Mr. Smith will be responsible for developing ... and visibility of MAP’s core message, products and initiatives. ... Marketing Manager at Cottonwood Financial in Irving, Texas, where ...
(Date:6/2/2015)... BC (PRWEB) June 02, 2015 ... announce the opening of Surrey’s first fertility ... and boasts a diverse, young community, with ... http://www.theglobeandmail.com/news/british-columbia/four-reasons-bcs-fastest-growing-city-is-a-political-powerhouse/article21408253/ , Until now patients ... have had to come into Vancouver or ...
(Date:6/2/2015)... 2015 Though almost the entire Park family ... the disease rule their lives. Organizing and hosting the June ... living life to the fullest and spreading awareness of HHT. ... but I won't live my life in a bubble because ... you'd want is to look back on your life with ...
Breaking Medicine News(10 mins):Health News:MedPro Healthcare Staffing Launches New MedPro Top Jobs App To Facilitate Job Search For Healthcare Professionals 2Health News:Claflin Medical Equipment (CME) Announces Acquisition of RSI Equipment, Inc. 2Health News:Jared Smith Joins MAP Health Management, LLC, as Vice President of Marketing 2Health News:Olive Fertility Centre Opens First Fertility Clinic in Surrey BC 2Health News:Family brings awareness to genetic disease at first Memphis walk 2
... ... led the fight against malaria, and I am encouraged to see proof in the World ... Daniel Carucci, Vice President for Global Health for the United Nations Foundation , ... Washington, D.C. (Vocus) December 15, 2009 -- ...
... changes increases risk in teens, study suggests , TUESDAY, ... or obese increases the risk of obstructive sleep apnea, ... for younger children, Australian researchers have found. , In ... to 18, who were referred for evaluation of snoring ...
... RPS Worldwide Launches ... known as one of the simplest and easiest business opportunities in America today. , ... Orlando, FL (PRWEB) December 15, 2009 ... and good will that is going to stick around long after the season,s end. ...
... decide benefits of imaging outweigh the risks , TUESDAY, ... a serious risk to people with heart pacemakers, researchers ... pacemakers to a simulated MRI magnetic field and then ... the pacemaker lead, where it would touch the interior ...
... as accurate a surgical method, with fewer complications, analysis ... it comes to diagnosing breast cancer, women and their ... the less invasive "core needle biopsy" procedure is nearly ... surgical procedure is, with fewer complications than the surgical ...
... , ... that a new market research report is available ... Manufacturing Industry in the U.S. and its International ... , The newly published In-Vitro Diagnostic Substance ...
Cached Medicine News:Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 2Health News:Puberty May Trigger Sleep Apnea in Overweight Kids 2Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 2Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 3Health News:Patients With Pacemakers Should Avoid MRI Scans 2Health News:Needle Biopsy Works Well in Diagnosing Breast Cancer 2Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8
Anti-Skin Antibody (ASA) Test Kit: Pemphigus and Bullous Pemphigoid...
... With advanced glass technologies and ... enhanced wide field views of the ... this advanced lens will provide image ... indirect method of examination for more ...
... Parisian Peel PRESTIGE system was designed with ... needs of the most demanding skin care ... U.S., the Parisian Peel PRESTIGE machine is ... Designed to offer maximum versatility and full ...
... Inverness Medical Professional Diagnostics is a ... extensive IFA and DFA test menu that ... and STDs as well as miscellaneous conjugates ... give you a wide assortment of substrates ...
Medicine Products: